Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study

Lancet

Volumn 369, Issue 9556, 2007, Pages 107-114

  Brouilette, Scott W ^a   Moore, Jasbir S ^a   McMahon, Alex D ^b   Thompson, John R ^a   Ford, Ian ^b   Shepherd, James ^b   Packard, Chris J ^b   Samani, Nilesh J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TELOMERE;

EID: 33846049673     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60071-3     Document Type: Article

References (34)

1. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
2. Davies M., Woolf N., Rowles P., and Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J 60 (1988) 459-464
3. Burrig K. The endothelium of advanced arteriosclerotic plaques in humans. Arterioscler Thromb 11 (1991) 1678-1689
4. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., and Komuro I. Endothelial cell senescence in human atherosclerosis. Role of telomere in endothelial dysfunction. Circulation 105 (2002) 1541-1544
5. Samani N., Boultby R., Butler R., Thompson J., and Goodall A. Telomere shortening in atherosclerosis. Lancet 358 (2002) 472-473
6. Brouilette S., Singh R., Thompson J., Goodall A., and Samani N. White cell telomere length and risk of myocardial infarction. Arterioscler Thromb Vasc Biol 23 (2003) 842-846
7. Cawthon R., Smith K., O'Brien E., Sivatchenko A., and Kerber R. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361 (2003) 393-395
8. Chan S., and Blackburn E. Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci 359 (2004) 109-121
9. Harley C., Futcher A., and Greider C. Telomeres shorten during ageing of human fibroblasts. Nature 345 (1990) 458-460
10. Olovnikov A. A theory of marginotomy. J Theor Biol 41 (1973) 181-190
11. Vaziri H., Dragowska W., Allsopp R., Thomas T., Harley C., and Lansdorp P. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89 (1992) 10114-10118
12. Vaziri H., Dragowska W., Allsopp R., Thomas T., Harley C., and Landsorp P. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91 (1994) 9857-9860
13. Allsopp R., and Harley C. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219 (1995) 130-136
14. Shepherd J., Cobbe S., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. The West of Scotland Coronary Prevention Study. N Engl J Med 333 (1995) 1301-1307
15. Cawthon R. Telomere measurement by quantitative PCR. Nucleic Acids Res 30 (2002) e47
16. Packard C., O'Reilly D., Caslake M., et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 343 (2000) 1148-1155
17. The WOSCOPS Study Group. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. Am J Cardiol 76 (1995) 485-491
18. Warton K., Foster N., Gold W., and Stanley K. A novel gene family induced by acute inflammation in endothelial cells. Gene 342 (2004) 84-95
19. Martin-Ruiz C., Gussekloo J., van Heemst D., von Zglinicki T., and Westendorp R. Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study. Aging Cell 4 (2005) 287-290
20. Martin-Ruiz C., Saretzki G., Petrie J., et al. Stochastic variation in telomere shortening rate causes heterogeneity of human fibroblast replicative life span. J Biol Chem 279 (2004) 17826-17833
21. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
22. Harrison D. Oxidative stress and coronary artery disease. Can J Cardiol 14 suppl D (1998) 30D-32D
23. von Zglinicki T. Role of oxidative stress in telomere regulation and replicative senescence. Ann N Y Acad Sci 908 (2000) 99-110
24. Valdes A., Andrew T., Gardner J., et al. Obesity, cigarette smoking, and telomere length in women. Lancet 366 (2005) 662-664
25. Jeanclos E., Krolewski A., Skurnick J., et al. Shortened telomere length in white blood cells of patients with IDDM. Diabetes 47 (1998) 482-486
26. Epel E., Blackburn E., Lin J., et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 49 (2004) 17312-17315
27. Slagboom P., Droog S., and Boomsma D. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 55 (1994) 876-882
28. Vasa-Nicotera M., Brouilette S., Mangino M., et al. Mapping of a major locus determining telomere length in humans. Am J Hum Genet 76 (2005) 147-151
29. Andrew T., Aviv A., Falchi M., et al. Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs. Am J Hum Genet 78 (2006) 480-486
30. Spyridopoulos I., Haendeler J., Urbich C., et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 110 (2004) 3136-3142
31. Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
32. Walter D., Rittig K., Bahlmann F., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
33. Takubo K., Izumiyama-Shimomura N., et al. Telomere lengths are characteristic in each human individual. Exp Gerontol 37 (2002) 523-531
34. Chang E., and Harley C. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92 (1995) 11190-11194